BeOne Medicines AG (HKG:6160)
Hong Kong · Delayed Price · Currency is HKD 174.00
+9.90 (6.03%)
At close: Mar 27, 2026
BeOne Medicines AG Market Cap
BeOne Medicines AG has a market cap or net worth of 245.81 billion as of March 27, 2026. Its market cap has increased by 15.58% in one year.
Market Cap
245.81B
Enterprise Value
218.75B
Revenue
41.59B
Ranking
n/a
PE Ratio
110.06
Stock Price
174.00
Market Cap Chart
Since February 3, 2016, BeOne Medicines AG's market cap has increased from 6.70B to 245.81B, an increase of 3,570.55%. That is a compound annual growth rate of 42.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 245.81B | -6.06% |
| Dec 31, 2025 | 261.67B | 71.29% |
| Dec 31, 2024 | 152.77B | 4.09% |
| Dec 29, 2023 | 146.76B | -17.60% |
| Dec 30, 2022 | 178.11B | -17.96% |
| Dec 31, 2021 | 217.12B | 19.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innovent Biologics | 137.77B |
| WuXi Biologics | 130.50B |
| Akeso | 113.95B |
| Sino Biopharmaceutical | 104.08B |
| Sichuan Kelun-Biotech Biopharmaceutical | 99.66B |
| RemeGen | 64.84B |
| 3SBio | 54.25B |
| Biocytogen Pharmaceuticals (Beijing) | 36.81B |